Ginkgo Bioworks Holdings, Inc. — Form 8-K Summary
Business context and reporting period
This Form 8-K, filed August 4, 2022, reports an event occurring August 2, 2022. Ginkgo Bioworks Holdings, Inc. is a Delaware corporation whose Class A common stock and warrants trade on the NYSE under DNA and DNA.WS, respectively.
Financial metrics and liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating guidance, or other financial metrics. No financial statements are included.
Material changes versus the prior comparable period
The Board appointed Kathy Hopinkah Hannan as an independent director effective August 2, 2022. Her term expires at the Company’s 2023 annual meeting of shareholders. She had not been appointed to any Board committees as of the filing.
Compensation, outlook, and other matters
- Under the Non-Employee Director Compensation Program, Dr. Hannan received options with a stated value of $400,000, plus prorated options and restricted stock units based on the date of the 2022 annual meeting.
- She is eligible for a $50,000 annual Board retainer and annual stock option and restricted stock unit awards under the program.
- She entered into the Company’s standard director and officer indemnification agreement.
- Dr. Hannan is a former senior executive of KPMG and currently serves on the boards of Annaly Capital Management, Otis Worldwide, and Carpenter Technology, among other organizations.
- The Company issued a press release announcing the appointment on August 4, 2022, filed as Exhibit 99.1.
Key facts for investors to verify
- The number of options and restricted stock units granted, exercise price, vesting terms, and accounting fair value are not specified in the filing text.
- Confirm the final compensation terms under the Company’s Non-Employee Director Compensation Program.
- Monitor whether Dr. Hannan is later assigned to Board committees.
- Review the attached press release and subsequent filings for additional governance, compensation, or related-party disclosures.